Literature DB >> 23388514

Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients.

Alex G Cuenca1, Lori F Gentile, M Cecilia Lopez, Ricardo Ungaro, Huazhi Liu, Wenzhong Xiao, Junhee Seok, Michael N Mindrinos, Darwin Ang, Tezcan Ozrazgat Baslanti, Azra Bihorac, Philip A Efron, Joseph Cuschieri, H Shaw Warren, Ronald G Tompkins, Ronald V Maier, Henry V Baker, Lyle L Moldawer.   

Abstract

OBJECTIVE: Many patients have complicated recoveries following severe trauma due to the development of organ injury. Physiological and anatomical prognosticators have had limited success in predicting clinical trajectories. We report on the development and retrospective validation of a simple genomic composite score that can be rapidly used to predict clinical outcomes.
DESIGN: Retrospective cohort study.
SETTING: Multi-institutional level 1 trauma centers. PATIENTS: Data were collected from 167 severely traumatized (injury severity score >15) adult (18-55 yr) patients.
METHODS: Microarray-derived genomic data obtained from 167 severely traumatized patients over 28 days were assessed for differences in messenger RNA abundance among individuals with different clinical trajectories. Once a set of genes was identified based on differences in expression over the entire study period, messenger RNA abundance from these subjects obtained in the first 24 hours was analyzed in a blinded fashion using a rapid multiplex platform, and genomic data reduced to a single metric.
RESULTS: From the existing genomic dataset, we identified 63 genes whose leukocyte expression differed between an uncomplicated and complicated clinical outcome over 28 days. Using a multiplex approach that can quantitate messenger RNA abundance in less than 12 hours, we reassessed total messenger RNA abundance from the first 24 hours after trauma and reduced the genomic data to a single composite score using the difference from reference. This composite score showed good discriminatory capacity to distinguish patients with a complicated outcome (area under a receiver-operator curve, 0.811; p <0.001). This was significantly better than the predictive power of either Acute Physiology and Chronic Health Evaluation II or new injury severity score scoring systems.
CONCLUSIONS: A rapid genomic composite score obtained in the first 24 hours after trauma can retrospectively identify trauma patients who are likely to develop complicated clinical trajectories. A novel platform is described in which this genomic score can be obtained within 12 hours of blood collection, making it available for clinical decision making.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23388514      PMCID: PMC3652285          DOI: 10.1097/CCM.0b013e318277131c

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  29 in total

1.  Whole blood and leukocyte RNA isolation for gene expression analyses.

Authors:  Robert J Feezor; Henry V Baker; Michael Mindrinos; Doug Hayden; Cynthia L Tannahill; Bernard H Brownstein; Adrian Fay; Sandra MacMillan; Jason Laramie; Wenzhong Xiao; Lyle L Moldawer; J Perren Cobb; Krzysztof Laudanski; Carol L Miller-Graziano; Ronald V Maier; David Schoenfeld; Ronald W Davis; Ronald G Tompkins
Journal:  Physiol Genomics       Date:  2004-11-17       Impact factor: 3.107

2.  Continuous flow microfluidic device for rapid erythrocyte lysis.

Authors:  Palaniappan Sethu; Melis Anahtar; Lyle L Moldawer; Ronald G Tompkins; Mehmet Toner
Journal:  Anal Chem       Date:  2004-11-01       Impact factor: 6.986

3.  Benchmarking outcomes in the critically injured trauma patient and the effect of implementing standard operating procedures.

Authors:  Joseph Cuschieri; Jeffrey L Johnson; Jason Sperry; Michael A West; Ernest E Moore; Joseph P Minei; Paul E Bankey; Avery B Nathens; Alex G Cuenca; Philip A Efron; Laura Hennessy; Wenzhong Xiao; Michael N Mindrinos; Grace P McDonald-Smith; Philip H Mason; Timothy R Billiar; David A Schoenfeld; H Shaw Warren; J Perren Cobb; Lyle L Moldawer; Ronald W Davis; Ronald V Maier; Ronald G Tompkins
Journal:  Ann Surg       Date:  2012-05       Impact factor: 12.969

4.  Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.

Authors:  E Abraham; P F Laterre; J Garbino; S Pingleton; T Butler; T Dugernier; B Margolis; K Kudsk; W Zimmerli; P Anderson; M Reynaert; D Lew; W Lesslauer; S Passe; P Cooper; A Burdeska; M Modi; A Leighton; M Salgo; P Van der Auwera
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

5.  p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.

Authors:  E Abraham; M P Glauser; T Butler; J Garbino; D Gelmont; P F Laterre; K Kudsk; H A Bruining; C Otto; E Tobin; C Zwingelstein; W Lesslauer; A Leighton
Journal:  JAMA       Date:  1997-05-21       Impact factor: 56.272

Review 6.  Such stuff as dreams are made on: mediator-directed therapy in sepsis.

Authors:  John C Marshall
Journal:  Nat Rev Drug Discov       Date:  2003-05       Impact factor: 84.694

7.  Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial.

Authors:  C J Fisher; G J Slotman; S M Opal; J P Pribble; R C Bone; G Emmanuel; D Ng; D C Bloedow; M A Catalano
Journal:  Crit Care Med       Date:  1994-01       Impact factor: 7.598

8.  Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome.

Authors:  J H Pruitt; M B Welborn; P D Edwards; T R Harward; J W Seeger; T D Martin; C Smith; J A Kenney; R I Wesdorp; S Meijer; M A Cuesta; A Abouhanze; E M Copeland; J Giri; J E Sims; L L Moldawer; H S Oldenburg
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

9.  Trauma fatalities: time and location of hospital deaths.

Authors:  Demetrios Demetriades; James Murray; Kiriakos Charalambides; Kathy Alo; George Velmahos; Peter Rhee; Linda Chan
Journal:  J Am Coll Surg       Date:  2004-01       Impact factor: 6.113

10.  A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group.

Authors:  R C Bone; R A Balk; A M Fein; T M Perl; R P Wenzel; H D Reines; R W Quenzer; T J Iberti; N Macintyre; R M Schein
Journal:  Crit Care Med       Date:  1995-06       Impact factor: 7.598

View more
  50 in total

1.  Prediction of multiple infections after severe burn trauma: a prospective cohort study.

Authors:  Shuangchun Yan; Amy Tsurumi; Yok-Ai Que; Colleen M Ryan; Arunava Bandyopadhaya; Alexander A Morgan; Patrick J Flaherty; Ronald G Tompkins; Laurence G Rahme
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

2.  Scudder Oration on Trauma. A century of evolution in trauma resuscitation.

Authors:  Ronald V Maier
Journal:  J Am Coll Surg       Date:  2014-05-27       Impact factor: 6.113

3.  The role of NIGMS P50 sponsored team science in our understanding of multiple organ failure.

Authors:  Frederick A Moore; Ernest E Moore; Timothy R Billiar; Yoram Vodovotz; Anirban Banerjee; Lyle L Moldawer
Journal:  J Trauma Acute Care Surg       Date:  2017-09       Impact factor: 3.313

4.  Polymorphism of heat shock protein 70-2 and enterocutaneous fistula in Chinese population.

Authors:  Jun Chen; Jian-An Ren; Gang Han; Guo-Sheng Gu; Ge-Fei Wang; Xiu-Wen Wu; Bo Zhou; Dong Hu; Yin Wu; Yun-Zhao Zhao; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

5.  A better understanding of why murine models of trauma do not recapitulate the human syndrome.

Authors:  Lori F Gentile; Dina C Nacionales; M Cecilia Lopez; Erin Vanzant; Angela Cuenca; Alex G Cuenca; Ricardo Ungaro; Tezcan Ozrazgat Baslanti; Bruce A McKinley; Azra Bihorac; Joseph Cuschieri; Ronald V Maier; Frederick A Moore; Christiaan Leeuwenburgh; Henry V Baker; Lyle L Moldawer; Philip A Efron
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

6.  Genomics of injury: The Glue Grant experience.

Authors:  Ronald G Tompkins
Journal:  J Trauma Acute Care Surg       Date:  2015-04       Impact factor: 3.313

7.  Sepsis Diagnostics: From Discovery to Application.

Authors:  Juan C Mira; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2017-01       Impact factor: 7.598

8.  Developing a clinically feasible personalized medicine approach to pediatric septic shock.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Thomas P Shanley; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Raj S Shekhar; Shira Gertz; Emily Dawson; Kelli Howard; Kelli Harmon; Eileen Beckman; Erin Frank; Christopher J Lindsell
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

Review 9.  Gene expression profiling in sepsis: timing, tissue, and translational considerations.

Authors:  David M Maslove; Hector R Wong
Journal:  Trends Mol Med       Date:  2014-02-15       Impact factor: 11.951

10.  Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma.

Authors:  Erin L Vanzant; Cecilia M Lopez; Tezcan Ozrazgat-Baslanti; Ricardo Ungaro; Ruth Davis; Alex G Cuenca; Lori F Gentile; Dina C Nacionales; Angela L Cuenca; Azra Bihorac; Christiaan Leeuwenburgh; Jennifer Lanz; Henry V Baker; Bruce McKinley; Lyle L Moldawer; Frederick A Moore; Philip A Efron
Journal:  J Trauma Acute Care Surg       Date:  2014-01       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.